Quris

About:

Quris provides an artificial intelligence platform that predicts which drug candidates will safely work in humans.

Website: https://www.quris.ai/

Top Investors: iAngels, Fusion, SoftBank Vision Fund, GlenRock Israel, Welltech Ventures

Description:

Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications. The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharma companies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing. Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.

Total Funding Amount:

$37M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2019-01-01

Contact Email:

contact(AT)quris.ai

Founders:

Isaac Bentwich, Yossi Haran

Number of Employees:

11-50

Last Funding Date:

2022-12-20

IPO Status:

Private

© 2024 MyAiNote.com